EXHIBIT 11. STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE
(Unaudited)
Eli Lilly and Company and Subsidiaries
Three Months Ended | ||||||||
March 31, | ||||||||
2008 | 2007 | |||||||
BASIC | ||||||||
Net income | $ | 1,064.3 | $ | 508.7 | ||||
Average number of common shares outstanding | 1,091.5 | 1,088.4 | ||||||
Contingently issuable shares | 2.4 | 1.3 | ||||||
Adjusted average shares | 1,093.9 | 1,089.7 | ||||||
Basic earnings per share | $ | .97 | $ | .47 | ||||
DILUTED | ||||||||
Net income | $ | 1,064.3 | $ | 508.7 | ||||
Average number of common shares outstanding | 1,091.5 | 1,088.4 | ||||||
Incremental shares – stock options and contingently issuable shares | 2.6 | 1.5 | ||||||
Adjusted average shares | 1,094.1 | 1,089.9 | ||||||
Diluted earnings per share | $ | .97 | $ | .47 | ||||
Dollars and shares in millions except per-share data.